Overview: Aardvark Therapeutics, Inc. (Nasdaq: AARD) is a clinical-stage biotech focused on therapies for metabolic diseases and Prader-Willi Syndrome (PWS) – a rare genetic disorder
Opening Recap Market Pulse: Gene-editing fervor rippled through biotech circles after a Mordor Intelligence report flagged double-digit growth in cell line development through 2031. Down
Introduction Eos Energy Enterprises, Inc. (NASDAQ: EOSE) is a battery technology company focused on zinc-based long-duration energy storage systems (investors.eose.com). The company went public via
